Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216

FDA recall notice · announced February 13, 2013 · Matrixx Initiatives

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

Reason for recall

Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.

Notes

Distribution: Nationwide.
Lot/code information: Lot # 2J23, Exp 09/15
Quantity: 46,752 bottles
Status: Terminated
Products in this recall event:
- Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of (D-155-2013)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.